Midostaurin treatment in FLT3-mutated acute myeloid leukemia and systemic mastocytosis

Sabine Kayser*ab, Mark J Levisc & Richard F Schlenkda Department of Internal Medicine V, University Hospital of Heidelberg, Heidelberg, Germanyb Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ) and Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germanyc Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USAd National Center for Tumor Diseases, Heidelberg, Germany